Pricing Log in Create free account

PMGC Holdings Inc. (ELAB) vs Matinas Biopharma Holdings, Inc. (MTNB)

PMGC Holdings Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. PMGC Holdings Inc. and Matinas Biopharma Holdings, Inc. are of similar size ($2.5M and $2.4M). Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,139.4% against 5.41%. Matinas Biopharma Holdings, Inc. has the higher net margin (0.00% vs −523.0%) and the lower return on invested capital (−419.3% vs 0.00%). Across the 17 metrics below, Matinas Biopharma Holdings, Inc. leads on 9 and PMGC Holdings Inc. on 8.

Valuation

Metric ELAB MTNB Biotechnology median
P/E n/m n/m 8.50
P/S 0.52 0.24 9.71
P/B 0.08 0.56 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.53 n/m 0.64
EV/Sales (6.66) 0.05 9.21
Earnings yield (38,441.73%) (348.48%) (33.15%)
Free cash flow yield (665.71%) (602.45%) (25.50%)

Profitability

Metric ELAB MTNB Biotechnology median
Gross margin 31.08% 0.00% 65.16%
Operating margin (458.63%) 0.00% 0.00%
Net margin (522.99%) 0.00% 0.00%
Free cash flow margin (348.69%) 0.00% 0.00%
Return on equity (104.60%) (154.28%) (56.36%)
Return on assets (58.71%) (98.53%) (48.04%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric ELAB MTNB Biotechnology median
Revenue growth (TTM) 5.41% 2,139.41% 6.02%
EPS growth (last fiscal year) 94.22% 62.08% 30.26%
Revenue growth, 5-year CAGR — 55.69% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ELAB MTNB Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 1.36 0.85 4.72
Net debt to EBITDA 0.87 0.62 0.96

Dividend

Metric ELAB MTNB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELAB MTNB Biotechnology median
Market cap 2.46m 2.37m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack